Skip to main content
Log in

Transcatheter aortic valve implantation

  • Published:
Current Treatment Options in Cardiovascular Medicine Aims and scope Submit manuscript

Opinion statement

Aortic stenosis is the most important valvular heart disease affecting the elderly population. Surgical aortic valve replacement is the mainstay of treatment, although a substantial number of patients are considered high risk for surgery. Many of these patients do not undergo surgery and have poor outcomes from medically treated symptomatic, severe aortic stenosis. Transcatheter aortic valve implantation (TAVI) provides a promising treatment option for some of these patients. Several devices are under investigation. The Edwards Sapien valve (Edwards Lifesciences, Irvine, CA) and the CoreValve (Medtronic, Minneapolis, MN) have the largest human experience to date. Initial data suggest that these devices have an acceptable safety profile and provide excellent hemodynamic relief of aortic stenosis. The Edwards Sapien valve is currently under investigation in the United States in the PARTNER (Placement of Aortic Transcatheter Valve) trial in high-risk surgical or inoperable patients; TAVI is available for clinical use in both Canada and Europe. TAVI is not used in low- or intermediate-risk surgical patients; however, future studies may prove its applicability in these subsets. The major complications of TAVI include access site-related problems and device malpositioning/migration. There are several new-generation prosthetic valves and delivery systems designed to be low profile and repositionable. Technical advances and refinement of the implantation methods may make TAVI even safer and ultimately a better treatment option, not only for patients with high surgical risk but also for those with moderate or low risk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Similar content being viewed by others

References and Recommended Reading

  1. Bonow RO, Carabello BA, Chatterjee K, et al.; American College of Cardiology/American Heart Association Task Force on Practice Guidelines: 2008 focused update incorporated into the ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to revise the 1998 guidelines for the management of patients with valvular heart disease). Endorsed by the Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, and Society of Thoracic Surgeons. J Am Coll Cardiol 2008, 52:e1–e142.

    Article  PubMed  Google Scholar 

  2. Iung B, Baron G, Butchart EG, et al.: A prospective survey of patients with valvular heart disease in Europe: The Euro Heart Survey on Valvular Heart Disease. Eur Heart J 2003, 24:1231–1243.

    Article  PubMed  Google Scholar 

  3. Nkomo VT, Gardin JM, Skelton TN, et al.: Burden of valvular heart diseases: a population-based study. Lancet 2006, 368:1005–1011.

    Article  PubMed  Google Scholar 

  4. Lindroos M, Kupari M, Heikkila J, Tilvis R: Prevalence of aortic valve abnormalities in the elderly: an echocardiographic study of a random population sample. J Am Coll Cardiol 1993, 21:1220–1225.

    Article  CAS  PubMed  Google Scholar 

  5. American College of Cardiology/American Heart Association Task Force on Practice Guidelines; Society of Cardiovascular Anesthesiologists; Society for Cardiovascular Angiography and Interventions; Society of Thoracic Surgeons, Bonow RO, Carabello BA, Kanu C, et al.: ACC/ AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 Guidelines for the Management of Patients With Valvular Heart Disease): developed in collaboration with the Society of Cardiovascular Anesthesiologists: endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. Circulation 2006, 114:e84–e231.

    Article  PubMed  Google Scholar 

  6. Horstkotte D, Loogen F: The natural history of aortic valve stenosis. Eur Heart J 1988, 9(Suppl E):57–64.

    PubMed  Google Scholar 

  7. Iivanainen AM, Lindroos M, Tilvis R, et al.: Natural history of aortic valve stenosis of varying severity in the elderly. Am J Cardiol 1996, 78:97–101.

    Article  CAS  PubMed  Google Scholar 

  8. Chizner MA, Pearle DL, deLeon AC Jr: The natural history of aortic stenosis in adults. Am Heart J 1980, 99:419–424.

    Article  CAS  PubMed  Google Scholar 

  9. Varadarajan P, Kapoor N, Bansal RC, Pai RG: Clinical profile and natural history of 453 nonsurgically managed patients with severe aortic stenosis. Ann Thorac Surg 2006, 82:2111–2115.

    Article  PubMed  Google Scholar 

  10. Iung B, Cachier A, Baron G, et al.: Decision-making in elderly patients with severe aortic stenosis: why are so many denied surgery? Eur Heart J 2005, 26:2714–2720.

    Article  PubMed  Google Scholar 

  11. Bouma BJ, van Den Brink RB, van Der Meulen JH, et al.: To operate or not on elderly patients with aortic stenosis: the decision and its consequences. Heart 1999, 82:143–148.

    CAS  PubMed  Google Scholar 

  12. Pai RG, Kapoor N, Bansal RC, Varadarajan P: Malignant natural history of asymptomatic severe aortic stenosis: benefit of aortic valve replacement. Ann Thorac Surg 2006, 82:2116–2122.

    Article  PubMed  Google Scholar 

  13. Bach DS, Cimino N, Deeb GM: Unoperated patients with severe aortic stenosis. J Am Coll Cardiol 2007, 50:2018–2019.

    Article  PubMed  Google Scholar 

  14. Cribier A, Eltchaninoff H, Tron C, et al.: Treatment of calcific aortic stenosis with the percutaneous heart valve: mid-term follow-up from the initial feasibility studies: the French experience. J Am Coll Cardiol 2006, 47:1214–1223.

    Article  PubMed  Google Scholar 

  15. Grube E, Laborde JC, Gerckens U, et al.: Percutaneous implantation of the CoreValve self-expanding valve prosthesis in high-risk patients with aortic valve disease: the Siegburg first-in-man study. Circulation 2006, 114:1616–1624.

    Article  PubMed  Google Scholar 

  16. Webb JG, Chandavimol M, Thompson CR, et al.: Percutaneous aortic valve implantation retrograde from the femoral artery. Circulation 2006, 113:842–850.

    Article  PubMed  Google Scholar 

  17. Vassiliades TA Jr, Block PC, Cohn LH, et al.: The clinical development of percutaneous heart valve technology. J Thorac Cardiovasc Surg 2005, 129:970–976.

    Article  PubMed  Google Scholar 

  18. Walther T, Simon P, Dewey T, et al.: Transapical minimally invasive aortic valve implantation: multicenter experience. Circulation 2007, 116(11 Suppl):I240–I245.

    PubMed  Google Scholar 

  19. Block PC, Bonhoeffer P: Percutaneous approaches to valvular heart disease. Curr Cardiol Rep 2005, 7:108–113.

    Article  PubMed  Google Scholar 

  20. Zajarias A, Cribier AG: Outcomes and safety of percutaneous aortic valve replacement. J Am Coll Cardiol 2009, 53:1829–1836.

    Article  PubMed  Google Scholar 

  21. Webb JG, Altwegg L, Boone RH, et al.: Transcatheter aortic valve implantation: impact on clinical and valve-related outcomes. Circulation 2009, 119:3009–3016.

    Article  PubMed  Google Scholar 

  22. Andersen HR, Knudsen LL, Hasenkam JM: Transluminal implantation of artificial heart valves. Description of a new expandable aortic valve and initial results with implantation by catheter technique in closed chest pigs. Eur Heart J 1992, 13:704–708.

    CAS  PubMed  Google Scholar 

  23. Webb JG, Altwegg L, Masson JB, et al.: A new transcatheter aortic valve and percutaneous valve delivery system. J Am Coll Cardiol 2009, 53:1855–1858.

    Article  PubMed  Google Scholar 

  24. Webb JG, Pasupati S, Humphries K, et al.: Percutaneous transarterial aortic valve replacement in selected high-risk patients with aortic stenosis. Circulation 2007, 116:755–763.

    Article  PubMed  Google Scholar 

  25. Lichtenstein SV, Cheung A, Ye J, et al.: Transapical transcatheter aortic valve implantation in humans: initial clinical experience. Circulation 2006, 114:591–596.

    Article  PubMed  Google Scholar 

  26. Ye J, Cheung A, Lichtenstein SV, et al.: Six-month outcome of transapical transcatheter aortic valve implantation in the initial seven patients. Eur J Cardiothorac Surg 2007, 31:16–21.

    Article  PubMed  Google Scholar 

  27. Walther T, Falk V, Borger MA, et al.: Minimally invasive transapical beating heart aortic valve implantation—proof of concept. Eur J Cardiothorac Surg 2007, 31:9–15.

    Article  PubMed  Google Scholar 

  28. Svensson LG, Dewey T, Kapadia S, et al.: United States feasibility study of transcatheter insertion of a stented aortic valve by the left ventricular apex. Ann Thorac Surg 2008, 86:46–54; discussion 55.

    Article  PubMed  Google Scholar 

  29. Grube E, Laborde JC, Zickmann B, et al.: First report on a human percutaneous transluminal implantation of a self-expanding valve prosthesis for interventional treatment of aortic valve stenosis. Catheter Cardiovasc Interv 2005, 66:465–469.

    Article  PubMed  Google Scholar 

  30. Grube E, Schuler G, Buellesfeld L, et al.: Percutaneous aortic valve replacement for severe aortic stenosis in high-risk patients using the second- and current third-generation self-expanding CoreValve prosthesis: device success and 30-day clinical outcome. J Am Coll Cardiol 2007, 50:69–76.

    Article  PubMed  Google Scholar 

  31. Kapadia SR, Svensson L, Tuzcu EM: Successful percutaneous management of left main trunk occlusion during percutaneous aortic valve replacement. Catheter Cardiovasc Interv 2009, 73:966–972.

    Article  PubMed  Google Scholar 

  32. Kodali S: Edward’s valve experience. Presented at the 20th Annual Transcatheter Cardiovascular Therapeutics Meeting. Washington, DC; October 12–17, 2008.

  33. Webb JG: Vancouver experience. Presented at the 20th Annual Transcatheter Cardiovascular Therapeutics Meeting. Washington, DC; October 12–17, 2008.

  34. Lefevre T: European experience with balloon expandable valve. Presented at the 20th Annual Transcatheter Cardiovascular Therapeutics Meeting. Washington, DC; October 12–17, 2008.

  35. Grube E, Buellesfeld L, Mueller R, et al.: Progress and current status of percutaneous aortic valve replacement: results of three device generations of the CoreValve revalving system. Circ Cardiovasc Interv 2008, 1:167–175.

    PubMed  Google Scholar 

  36. Bleiziffer S, Ruge H, Mazzitelli D, et al.: Results of percutaneous and transapical transcatheter aortic valve implantation performed by a surgical team. Eur J Cardiothorac Surg 2009, 35:615–620; discussion 620–621.

    Article  PubMed  Google Scholar 

  37. Tamburino C, Capodanno D, Mul EM, et al.: Procedural success and 30-day clinical outcomes after percutaneous aortic valve replacement using current third-generation self-expanding CoreValve prosthesis. J Invasive Cardiol 2009, 21:93–98.

    PubMed  Google Scholar 

  38. Laborde JC: CoreValve experience. Presented at the 58th Annual Meeting of the American College of Cardiology. Orlando, FL; March 29–31, 2009.

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to E. Murat Tuzcu.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Kapadia, S.R., Murat Tuzcu, E. Transcatheter aortic valve implantation. Curr Treat Options Cardio Med 11, 467–475 (2009). https://doi.org/10.1007/s11936-009-0049-x

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11936-009-0049-x

Keywords

Navigation